Biorem Inc Stock Market Value
| BRM Stock | CAD 3.00 0.02 0.67% |
| Symbol | BioRem |
BioRem Inc Price To Book Ratio
BioRem 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioRem's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioRem.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in BioRem on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding BioRem Inc or generate 0.0% return on investment in BioRem over 30 days. BioRem is related to or competes with Thermal Energy, BluMetric Environmental, Vitreous Glass, and CHAR Technologies. BIOREM Inc., an environmental biotechnology company, designs, manufactures, and sells air emissions control systems that... More
BioRem Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioRem's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioRem Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.44 | |||
| Information Ratio | 0.1122 | |||
| Maximum Drawdown | 20.56 | |||
| Value At Risk | (3.56) | |||
| Potential Upside | 6.93 |
BioRem Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioRem's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioRem's standard deviation. In reality, there are many statistical measures that can use BioRem historical prices to predict the future BioRem's volatility.| Risk Adjusted Performance | 0.1244 | |||
| Jensen Alpha | 0.3201 | |||
| Total Risk Alpha | (0.06) | |||
| Sortino Ratio | 0.1564 | |||
| Treynor Ratio | 0.3431 |
BioRem Inc Backtested Returns
BioRem appears to be unstable, given 3 months investment horizon. BioRem Inc secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for BioRem Inc, which you can use to evaluate the volatility of the firm. Please makes use of BioRem's Downside Deviation of 2.44, mean deviation of 2.47, and Risk Adjusted Performance of 0.1244 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, BioRem holds a performance score of 8. The firm shows a Beta (market volatility) of 1.49, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, BioRem will likely underperform. Please check BioRem's sortino ratio, skewness, period momentum indicator, as well as the relationship between the potential upside and rate of daily change , to make a quick decision on whether BioRem's price patterns will revert.
Auto-correlation | 0.36 |
Below average predictability
BioRem Inc has below average predictability. Overlapping area represents the amount of predictability between BioRem time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioRem Inc price movement. The serial correlation of 0.36 indicates that just about 36.0% of current BioRem price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.36 | |
| Spearman Rank Test | 0.6 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
BioRem Inc lagged returns against current returns
Autocorrelation, which is BioRem stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioRem's stock expected returns. We can calculate the autocorrelation of BioRem returns to help us make a trade decision. For example, suppose you find that BioRem has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioRem regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioRem stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioRem stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioRem stock over time.
Current vs Lagged Prices |
| Timeline |
BioRem Lagged Returns
When evaluating BioRem's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioRem stock have on its future price. BioRem autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioRem autocorrelation shows the relationship between BioRem stock current value and its past values and can show if there is a momentum factor associated with investing in BioRem Inc.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioRem Stock Analysis
When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.